Oleozon in the treatment of chronic edematous and fibroedematous gingivitis
Original paper Author Trujillo Gálvez B, Lima Hernández, LB, Plasencia Iglesias, MB,...
Read MoreSelect Page
Posted by AEPROMO | 4 Jun, 2021 | Volume 11 (2021) |
Original paper Author Trujillo Gálvez B, Lima Hernández, LB, Plasencia Iglesias, MB,...
Read MorePosted by AEPROMO | 4 Jun, 2021 | Volume 11 (2021) |
Case report Author García, Walter Mea Abstract The objective of this work was to enhance...
Read MorePosted by AEPROMO | 4 Jun, 2021 | Volume 11 (2021) |
Case report Author Jaime Jean Pierre Cachay Morales, Jaime Ulises Cachay Agurto Abstract...
Read MorePosted by AEPROMO | 4 Jun, 2021 | Volume 11 (2021) |
Case report Author Jose Antonio Sáenz López Abstract Low back pain is the most frequent...
Read MorePosted by AEPROMO | 4 Jun, 2021 | Volume 11 (2021) |
Case report Author José Ignacio Calvo Sáez, Mª Angeles Armendariz Mekjavich, Pilar Anadón...
Read MoreVolume 13 (2023) STRONG TRIUMPH OF DRA. ADRIANA SCHWARTZ AND AEPROMO IN FAVOR OF OZONE THERAPY
Volume 11 (2021) Who decides what a pseudo-therapy is? Evidence vs hasty opinions on ozone
Volume 11 (2021) Does the United States Drug Agency (FDA) make scientific decisions?
Volume 2 (2012) RECTAL INSUFFLATIONS ARE A VALID WAY IN OZONETHERAPY
If you wish to submit your paper, please read our Publication Guidelines carefully
AEPROMO y Ozone Therapy Global Journal tiene entre sus primeras prioridades garantizar la ética y calidad de los artículos publicados.
Como compromiso con la comunidad científica, suscribimos el código de conducta y las buenas prácticas definidas por el Comité sobre la Ética de la Publicación (COPE) para editores de revistas científicas.
Este código se puede consultar en este enlace: Code of Conduct for Journal Editors